Two in three adults in England are overweight or obese - and 26 per cent of us have learned all we know about treatments like ...

The improved engagement with HF patients intended to optimize GDMT was very modest, but did lead to increased use of MRAs.

A new study has found that the groundbreaking new class of weight loss drugs may not only be good at treating diabetes, but ...

The best online providers offer strong support services to help you succeed in your GLP-1 weight loss journey.

Jim Gaffigan is the latest celebrity opening up about his major weight loss with the help of popular prescription medications ...

Former PM Boris Johnson argues freedom of speech is 'under threat' in new column. 'Police the streets not the Tweets' is ...

Eli Lilly (NYSE: LLY) sells a broad range of pharmaceuticals treating various diseases, but one portfolio in particular has ...

Comedian Jim Gaffigan, whose new stand-up special, 'The Skinny', premieres on Nov. 22 on Hulu, has lost 50 lbs. with the help ...

Eli Lilly's Phase 3 study shows tirzepatide significantly cuts type 2 diabetes risk and supports 22.9% average weight loss in adults over three years.

A phase 3 trial found that Eli Lilly's tirzepatide significantly reduced the risk of progression to Type 2 diabetes in prediabetic adults over a three-year period. Nearly 99% of individuals treated ...

Has something changed regarding Eli Lilly or Regeneron's thesis, or is the recent dip an excellent opportunity to invest in ...